AEON Biopharma Inc
AEON.WS
AEON.WS was delisted on the 26th of April, 2024.
42 hedge funds and large institutions have $572K invested in AEON Biopharma Inc in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 10 closing their positions.
14% less funds holding
Funds holding: 49 → 42 (-7)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
71% less call options, than puts
Call options by funds: $19K | Put options by funds: $66K
80% less capital invested
Capital invested by funds: $2.87M → $572K (-$2.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
+$7.32K |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$3.13K |
| 3 |
CAC
Cowen and Company
New York
|
+$1.76K |
| 4 |
VF
Virtu Financial
New York
|
+$1.35K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$536 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Athos Capital
Hong Kong
|
-$302K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$54.8K |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
-$28.3K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.37K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$4.33K |
AEON.WS Hedge Fund Activity: Q2 2023 in Review
42 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q2 2023, worth a combined $572K — down 80% from $2.87M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AEON.WS and 4 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Sandia Investment Management, opening a new position worth an estimated $7.32K. The largest seller was Athos Capital, exiting entirely with an estimated $302K sold.
- 42 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q2 2023, down from 49 in Q1 2023.
- Funds reported $572K of AEON Biopharma Inc stock for Q2 2023, down 80% quarter-over-quarter.
- 4 funds opened new AEON Biopharma Inc positions in Q2 2023 and 10 closed out, a net change of -6 holders.
- The largest AEON Biopharma Inc buyer in Q2 2023 was Sandia Investment Management, an estimated $7.32K added.
- The largest AEON Biopharma Inc seller in Q2 2023 was Athos Capital, an estimated $302K sold.
Based on aggregated 13F filings for Q2 2023.